<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>7708866</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">33395998</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">7708866</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pii">S2213-1582(20)30346-6</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.1016/j.nicl.2020.102509</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="publisher-id">102509</article-id></all-ids><extracted-table><table-id>t0005</table-id><table-label>Table 1</table-label><table-caption>Sociodemographic, clinical and neuropsychological features of ALS patients and healthy controls at baseline.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" position="float" id="t0005"><label>Table 1</label><caption><p>Sociodemographic, clinical and neuropsychological features of ALS patients and healthy controls at baseline.</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th><bold>ALS</bold></th><th><bold>HC</bold></th><th><bold>P-value</bold></th></tr></thead><tbody><tr><td><bold>N</bold></td><td>25</td><td>39</td><td/></tr><tr><td>Sex, women</td><td>6 (25%)</td><td>19 (47.5%)</td><td align="char">0.07</td></tr><tr><td>Age at MRI [years]</td><td>61.56 ± 10.79</td><td>64.17 ± 7.44</td><td align="char">0.29</td></tr><tr><td>Education [years]</td><td>10.96 ± 3.92</td><td>12.28 ± 4.15</td><td align="char">0.21</td></tr><tr><td>Disease duration [months]</td><td>17.56 ± 14.06</td><td>–</td><td align="char">–</td></tr><tr><td>ALSFRS-R baseline, 0–48</td><td>42.36 ± 4.02</td><td>–</td><td align="char">–</td></tr><tr><td>Disease Progression Rate</td><td>0.47 ± 0.40</td><td>–</td><td align="char">–</td></tr><tr><td>Site of onset (limb/bulbar/limb + bulbar)</td><td>21/3/1</td><td>–</td><td align="char">–</td></tr><tr><td>Visit time interval [months]</td><td>5.1 ± 2.1</td><td>–</td><td align="char">–</td></tr><tr><td><bold>Global cognition</bold></td><td/><td/><td/></tr><tr><td>MMSE</td><td>28.94 ± 1.14</td><td>29.33 ± 0.92</td><td align="char">0.21</td></tr><tr><td><bold>Memory</bold></td><td/><td/><td/></tr><tr><td>Digit span, forward</td><td>6.20 ± 1.48</td><td>6.10 ± 0.98</td><td align="char">0.85</td></tr><tr><td>RAVLT, immediate</td><td>47.00 ± 11.13</td><td>45.55 ± 10.05</td><td align="char">0.75</td></tr><tr><td>RAVLT, delayed</td><td>8.50 ± 2.43</td><td>9.03 ± 3.32</td><td align="char">0.71</td></tr><tr><td>Spatial span, forward</td><td>–</td><td>4.83 ± 1.01</td><td align="char">–</td></tr><tr><td><bold>Executive function</bold></td><td/><td/><td/></tr><tr><td>CPM</td><td>32.50 ± 2.88</td><td>31.11 ± 3.19</td><td align="char">0.34</td></tr><tr><td>Digit span, backward</td><td>5.00 ± 1.23</td><td>4.40 ± 1.16</td><td align="char">0.30</td></tr><tr><td>CET</td><td>13.00 ± 4.42</td><td>–</td><td align="char">–</td></tr><tr><td>Weigl’s test</td><td>10.83 ± 2.71</td><td>–</td><td align="char">–</td></tr><tr><td>WCST, perseverative responses</td><td>5.50 ± 1.73</td><td>11.75 ± 7.27</td><td align="char">0.13</td></tr><tr><td><bold>Language</bold></td><td/><td/><td/></tr><tr><td>BADA (nouns)</td><td>30.00 ± 0.00</td><td>29.31 ± 1.45</td><td align="char">0.08</td></tr><tr><td>BADA (actions)</td><td>27.50 ± 0.83</td><td>27.25 ± 1.77</td><td align="char">0.75</td></tr><tr><td><bold>Fluency</bold></td><td/><td/><td/></tr><tr><td>Phonemic fluency</td><td>33.05 ± 12.63</td><td>38.21 ± 8.54</td><td align="char">0.11</td></tr><tr><td>Phonemic fluency, Index</td><td>6.28 ± 3.54</td><td>4.82 ± 2.27</td><td align="char">0.14</td></tr><tr><td>Semantic fluency</td><td>42.48 ± 10.39</td><td>44.03 ± 8.66</td><td align="char">0.57</td></tr><tr><td>Semantic fluency, Index</td><td>3.89 ± 1.09</td><td>3.93 ± 1.08</td><td align="char">0.85</td></tr><tr><td><bold>Mood &amp; Behavior</bold></td><td/><td/><td/></tr><tr><td>BDI</td><td>10.32 ± 6.78</td><td>4.35 ± 3.64</td><td align="char">0.002<bold>*</bold></td></tr><tr><td>ALS-FTD-Q</td><td>22.00 ± 10.74</td><td>–</td><td align="char">–</td></tr></tbody></table><table-wrap-foot><fn><p>Values denote mean ± standard deviations or numbers (percentages). Neuropsychological values are reported as raw scores. P-values refer to T-test models and Pearson’s χ<sup>2</sup> test. *=significant differences between groups at p &lt; 0.05. Abbreviations: ALS = amyotrophic lateral sclerosis; ALS-FTD-Q = amyotrophic lateral sclerosis-frontotemporal dementia-questionnaire; ALSFRS-R = ALS Functional Rating Scale Revised; BADA = battery for the analysis of aphasic deficits; BDI = Beck Depression Inventory; CET = cognitive estimation test; CPM = coloured progressive matrices; HC = healthy controls; MMSE = mini-mental state examination; MRI = Magnetic Resonance Imaging. RAVLT = Rey auditory verbal learning test; WCST = Wisconsin card sorting test. Disease Progression Rate has been obtained as following: (48–ALSFRS-R score)/time between symptom onset and first visit. Fluency indices have been obtained as following: time for generation condition - time for control condition (reading or writing generated words)/total number of items generated.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Sociodemographic, clinical and neuropsychological features of ALS patients and healthy controls at baseline.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th/><th>ALS</th><th>HC</th><th>P-value</th></tr></thead><tbody><tr><td>N</td><td>25</td><td>39</td><td/></tr><tr><td>Sex, women</td><td>6 (25%)</td><td>19 (47.5%)</td><td align="char">0.07</td></tr><tr><td>Age at MRI [years]</td><td>61.56 ± 10.79</td><td>64.17 ± 7.44</td><td align="char">0.29</td></tr><tr><td>Education [years]</td><td>10.96 ± 3.92</td><td>12.28 ± 4.15</td><td align="char">0.21</td></tr><tr><td>Disease duration [months]</td><td>17.56 ± 14.06</td><td>–</td><td align="char">–</td></tr><tr><td>ALSFRS-R baseline, 0–48</td><td>42.36 ± 4.02</td><td>–</td><td align="char">–</td></tr><tr><td>Disease Progression Rate</td><td>0.47 ± 0.40</td><td>–</td><td align="char">–</td></tr><tr><td>Site of onset (limb/bulbar/limb + bulbar)</td><td>21/3/1</td><td>–</td><td align="char">–</td></tr><tr><td>Visit time interval [months]</td><td>5.1 ± 2.1</td><td>–</td><td align="char">–</td></tr><tr><td>Global cognition</td><td/><td/><td/></tr><tr><td>MMSE</td><td>28.94 ± 1.14</td><td>29.33 ± 0.92</td><td align="char">0.21</td></tr><tr><td>Memory</td><td/><td/><td/></tr><tr><td>Digit span, forward</td><td>6.20 ± 1.48</td><td>6.10 ± 0.98</td><td align="char">0.85</td></tr><tr><td>RAVLT, immediate</td><td>47.00 ± 11.13</td><td>45.55 ± 10.05</td><td align="char">0.75</td></tr><tr><td>RAVLT, delayed</td><td>8.50 ± 2.43</td><td>9.03 ± 3.32</td><td align="char">0.71</td></tr><tr><td>Spatial span, forward</td><td>–</td><td>4.83 ± 1.01</td><td align="char">–</td></tr><tr><td>Executive function</td><td/><td/><td/></tr><tr><td>CPM</td><td>32.50 ± 2.88</td><td>31.11 ± 3.19</td><td align="char">0.34</td></tr><tr><td>Digit span, backward</td><td>5.00 ± 1.23</td><td>4.40 ± 1.16</td><td align="char">0.30</td></tr><tr><td>CET</td><td>13.00 ± 4.42</td><td>–</td><td align="char">–</td></tr><tr><td>Weigl’s test</td><td>10.83 ± 2.71</td><td>–</td><td align="char">–</td></tr><tr><td>WCST, perseverative responses</td><td>5.50 ± 1.73</td><td>11.75 ± 7.27</td><td align="char">0.13</td></tr><tr><td>Language</td><td/><td/><td/></tr><tr><td>BADA (nouns)</td><td>30.00 ± 0.00</td><td>29.31 ± 1.45</td><td align="char">0.08</td></tr><tr><td>BADA (actions)</td><td>27.50 ± 0.83</td><td>27.25 ± 1.77</td><td align="char">0.75</td></tr><tr><td>Fluency</td><td/><td/><td/></tr><tr><td>Phonemic fluency</td><td>33.05 ± 12.63</td><td>38.21 ± 8.54</td><td align="char">0.11</td></tr><tr><td>Phonemic fluency, Index</td><td>6.28 ± 3.54</td><td>4.82 ± 2.27</td><td align="char">0.14</td></tr><tr><td>Semantic fluency</td><td>42.48 ± 10.39</td><td>44.03 ± 8.66</td><td align="char">0.57</td></tr><tr><td>Semantic fluency, Index</td><td>3.89 ± 1.09</td><td>3.93 ± 1.08</td><td align="char">0.85</td></tr><tr><td>Mood &amp; Behavior</td><td/><td/><td/></tr><tr><td>BDI</td><td>10.32 ± 6.78</td><td>4.35 ± 3.64</td><td align="char">0.002*</td></tr><tr><td>ALS-FTD-Q</td><td>22.00 ± 10.74</td><td>–</td><td align="char">–</td></tr></tbody></table></div>Values denote mean ± standard deviations or numbers (percentages). Neuropsychological values are reported as raw scores. P-values refer to T-test models and Pearson’s χ2 test. *=significant differences between groups at p &lt; 0.05. Abbreviations: ALS = amyotrophic lateral sclerosis; ALS-FTD-Q = amyotrophic lateral sclerosis-frontotemporal dementia-questionnaire; ALSFRS-R = ALS Functional Rating Scale Revised; BADA = battery for the analysis of aphasic deficits; BDI = Beck Depression Inventory; CET = cognitive estimation test; CPM = coloured progressive matrices; HC = healthy controls; MMSE = mini-mental state examination; MRI = Magnetic Resonance Imaging. RAVLT = Rey auditory verbal learning test; WCST = Wisconsin card sorting test. Disease Progression Rate has been obtained as following: (48–ALSFRS-R score)/time between symptom onset and first visit. Fluency indices have been obtained as following: time for generation condition - time for control condition (reading or writing generated words)/total number of items generated.</transformed-table></extracted-table><extracted-table><table-id>t0010</table-id><table-label>Table 2</table-label><table-caption>Cognitive performance of ALS patients at the Test of Attentional Performance (TAP), fluency tests and coloured progressive matrices at baseline and at six months of follow-up.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" position="float" id="t0010"><label>Table 2</label><caption><p>Cognitive performance of ALS patients at the Test of Attentional Performance (TAP), fluency tests and coloured progressive matrices at baseline and at six months of follow-up.</p></caption><table frame="hsides" rules="groups"><thead><tr><th><bold>Outcome</bold></th><th><bold>Value</bold></th><th><bold>Baseline</bold></th><th><bold>Month 6</bold></th><th><bold>P-value</bold></th></tr></thead><tbody><tr><td><bold>Alertness, no cue</bold></td><td>RT</td><td>344.00 ± 131.86</td><td>383.96 ± 210.29</td><td align="char">0.01*</td></tr><tr><td><bold>Alertness, no cue</bold></td><td>Omissions</td><td>0.00 ± 0.00</td><td>0.20 ± 1.00</td><td align="char">0.13</td></tr><tr><td><bold>Alertness, no cue</bold></td><td>T-MDN</td><td>40.17 ± 11.54</td><td>37.13 ± 10.76</td><td align="char">0.02*</td></tr><tr><td><bold>Alertness with cue</bold></td><td>RT</td><td>312.32 ± 98.98</td><td>349.48 ± 166.42</td><td align="char">0.01*</td></tr><tr><td><bold>Alertness, with cue</bold></td><td>Omissions</td><td>0.00 ± 0.00</td><td>0.04 ± 0.20</td><td align="char">0.35</td></tr><tr><td><bold>Alertness with cue</bold></td><td>T-MDN</td><td>41.71 ± 11.99</td><td>39.13 ± 11.53</td><td align="char">0.06</td></tr><tr><td><bold>Sustained attention</bold></td><td>RT</td><td>715.64 ± 120.89</td><td>718.55 ± 141.13</td><td align="char">0.84</td></tr><tr><td><bold>Sustained attention</bold></td><td>Errors</td><td>11.27 ± 9.89</td><td>12.32 ± 16.98</td><td align="char">0.64</td></tr><tr><td><bold>Sustained attention</bold></td><td>T-MDN</td><td>41.92 ± 7.84</td><td>41.50 ± 8.70</td><td align="char">0.79</td></tr><tr><td><bold>Go/NoGo</bold></td><td>RT</td><td>643.35 ± 103.20</td><td>665.00 ± 115.74</td><td align="char">0.15</td></tr><tr><td><bold>Go/NoGo</bold></td><td>Errors</td><td>2.22 ± 3.94</td><td>1.39 ± 2.46</td><td align="char">0.17</td></tr><tr><td><bold>Go/NoGo</bold></td><td>T-MDN</td><td>45.09 ± 13.14</td><td>42.68 ± 15.19</td><td align="char">0.16</td></tr><tr><td><bold>Incompatibility</bold></td><td>RT</td><td>633.72 ± 157.42</td><td>634.94 ± 181.54</td><td align="char">0.96</td></tr><tr><td><bold>Incompatibility</bold></td><td>Errors</td><td>5.00 ± 7.66</td><td>3.55 ± 5.38</td><td align="char">0.19</td></tr><tr><td><bold>Incompatibility</bold></td><td>T-MDN</td><td>42.44 ± 11.80</td><td>41.83 ± 12.93</td><td align="char">0.76</td></tr><tr><td><bold>Divided attention</bold></td><td>RT</td><td>562.40 ± 87.18</td><td>568.52 ± 127.67</td><td align="char">0.74</td></tr><tr><td><bold>Divided attention</bold></td><td>Omissions</td><td>0.56 ± 1.12</td><td>0.32 ± 0.85</td><td align="char">0.46</td></tr><tr><td><bold>Divided attention</bold></td><td>T-MDN</td><td>47.24 ± 14.47</td><td>48.24 ± 13.50</td><td align="char">0.67</td></tr><tr><td><bold>Crossmodal</bold></td><td>RT</td><td>518.73 ± 119.30</td><td>514.59 ± 135.36</td><td align="char">0.87</td></tr><tr><td><bold>Crossmodal</bold></td><td>Errors</td><td>2.14 ± 4.04</td><td>1.18 ± 2.06</td><td align="char">0.21</td></tr><tr><td><bold>Crossmodal</bold></td><td>T-MDN</td><td>44.50 ± 7.07</td><td>46.50 ± 10.41</td><td align="char">0.52</td></tr><tr><td>Letter fluency, Index</td><td>Adjusted score</td><td>6.28 ± 3.54</td><td>8.43 ± 10.69</td><td align="char">0.40</td></tr><tr><td>Category fluency, Index</td><td>Adjusted score</td><td>3.89 ± 1.09</td><td>4.37 ± 2.01</td><td align="char">0.32</td></tr><tr><td>CPM</td><td>Correct items</td><td>32.50 ± 2.88</td><td>31.29 ± 4.15</td><td align="char">0.05</td></tr></tbody></table><table-wrap-foot><fn><p>Values denote means (reaction times or accuracy) and T-value of the median (T-MDN) ± standard deviations. RT (reaction times) have been reported in terms of seconds. Comparisons among the two time points were assessed using general linear models for repeated-measures, corrected for changes at the ALS Functional Rating Scale Revised (ALSFRS-R) and time between scans, adjusting for multiple comparisons using Bonferroni’s correction. *=significant differences between groups at p &lt; 0.05. T is a standardized value with a mean of 50 and a standard deviation of 10. Higher T values mean better performance. Abbreviations: CPM = coloured progressive matrices. Fluency indices have been obtained as follows: time for generation condition - time for control condition (reading or writing generated words)/total number of items generated.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Cognitive performance of ALS patients at the Test of Attentional Performance (TAP), fluency tests and coloured progressive matrices at baseline and at six months of follow-up.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th>Outcome</th><th>Value</th><th>Baseline</th><th>Month 6</th><th>P-value</th></tr></thead><tbody><tr><td>Alertness, no cue</td><td>RT</td><td>344.00 ± 131.86</td><td>383.96 ± 210.29</td><td align="char">0.01*</td></tr><tr><td>Alertness, no cue</td><td>Omissions</td><td>0.00 ± 0.00</td><td>0.20 ± 1.00</td><td align="char">0.13</td></tr><tr><td>Alertness, no cue</td><td>T-MDN</td><td>40.17 ± 11.54</td><td>37.13 ± 10.76</td><td align="char">0.02*</td></tr><tr><td>Alertness with cue</td><td>RT</td><td>312.32 ± 98.98</td><td>349.48 ± 166.42</td><td align="char">0.01*</td></tr><tr><td>Alertness, with cue</td><td>Omissions</td><td>0.00 ± 0.00</td><td>0.04 ± 0.20</td><td align="char">0.35</td></tr><tr><td>Alertness with cue</td><td>T-MDN</td><td>41.71 ± 11.99</td><td>39.13 ± 11.53</td><td align="char">0.06</td></tr><tr><td>Sustained attention</td><td>RT</td><td>715.64 ± 120.89</td><td>718.55 ± 141.13</td><td align="char">0.84</td></tr><tr><td>Sustained attention</td><td>Errors</td><td>11.27 ± 9.89</td><td>12.32 ± 16.98</td><td align="char">0.64</td></tr><tr><td>Sustained attention</td><td>T-MDN</td><td>41.92 ± 7.84</td><td>41.50 ± 8.70</td><td align="char">0.79</td></tr><tr><td>Go/NoGo</td><td>RT</td><td>643.35 ± 103.20</td><td>665.00 ± 115.74</td><td align="char">0.15</td></tr><tr><td>Go/NoGo</td><td>Errors</td><td>2.22 ± 3.94</td><td>1.39 ± 2.46</td><td align="char">0.17</td></tr><tr><td>Go/NoGo</td><td>T-MDN</td><td>45.09 ± 13.14</td><td>42.68 ± 15.19</td><td align="char">0.16</td></tr><tr><td>Incompatibility</td><td>RT</td><td>633.72 ± 157.42</td><td>634.94 ± 181.54</td><td align="char">0.96</td></tr><tr><td>Incompatibility</td><td>Errors</td><td>5.00 ± 7.66</td><td>3.55 ± 5.38</td><td align="char">0.19</td></tr><tr><td>Incompatibility</td><td>T-MDN</td><td>42.44 ± 11.80</td><td>41.83 ± 12.93</td><td align="char">0.76</td></tr><tr><td>Divided attention</td><td>RT</td><td>562.40 ± 87.18</td><td>568.52 ± 127.67</td><td align="char">0.74</td></tr><tr><td>Divided attention</td><td>Omissions</td><td>0.56 ± 1.12</td><td>0.32 ± 0.85</td><td align="char">0.46</td></tr><tr><td>Divided attention</td><td>T-MDN</td><td>47.24 ± 14.47</td><td>48.24 ± 13.50</td><td align="char">0.67</td></tr><tr><td>Crossmodal</td><td>RT</td><td>518.73 ± 119.30</td><td>514.59 ± 135.36</td><td align="char">0.87</td></tr><tr><td>Crossmodal</td><td>Errors</td><td>2.14 ± 4.04</td><td>1.18 ± 2.06</td><td align="char">0.21</td></tr><tr><td>Crossmodal</td><td>T-MDN</td><td>44.50 ± 7.07</td><td>46.50 ± 10.41</td><td align="char">0.52</td></tr><tr><td>Letter fluency, Index</td><td>Adjusted score</td><td>6.28 ± 3.54</td><td>8.43 ± 10.69</td><td align="char">0.40</td></tr><tr><td>Category fluency, Index</td><td>Adjusted score</td><td>3.89 ± 1.09</td><td>4.37 ± 2.01</td><td align="char">0.32</td></tr><tr><td>CPM</td><td>Correct items</td><td>32.50 ± 2.88</td><td>31.29 ± 4.15</td><td align="char">0.05</td></tr></tbody></table></div>Values denote means (reaction times or accuracy) and T-value of the median (T-MDN) ± standard deviations. RT (reaction times) have been reported in terms of seconds. Comparisons among the two time points were assessed using general linear models for repeated-measures, corrected for changes at the ALS Functional Rating Scale Revised (ALSFRS-R) and time between scans, adjusting for multiple comparisons using Bonferroni’s correction. *=significant differences between groups at p &lt; 0.05. T is a standardized value with a mean of 50 and a standard deviation of 10. Higher T values mean better performance. Abbreviations: CPM = coloured progressive matrices. Fluency indices have been obtained as follows: time for generation condition - time for control condition (reading or writing generated words)/total number of items generated.</transformed-table></extracted-table></extracted-tables-set>